Use of targeted cross-linked nanoparticles for in vivo gene delivery
    5.
    发明授权
    Use of targeted cross-linked nanoparticles for in vivo gene delivery 失效
    使用靶向交联纳米粒子进行体内基因递送

    公开(公告)号:US07514098B2

    公开(公告)日:2009-04-07

    申请号:US10159241

    申请日:2002-05-30

    摘要: The in vivo delivery of nucleic acids is targeted by delivery of the nucleic acid in a complex with cross-linked nanoparticles; where the nanoparticles comprise cross-linked neutral amphipathic molecules, cationic amphipathic molecules and targeting amphipathic molecules. Optionally the cationic and targeting amphipathic molecules are also cross-linked. A targeting moiety present on the targeting amphipathic molecule provides for selective delivery of the complex to a predetermined target site, e.g. blood vessels, endothelial cells, tumor cells, liver cells, and the like.

    摘要翻译: 核酸的体内递送通过将核酸递送到具有交联纳米颗粒的复合物中来靶向; 其中纳米颗粒包含交联的中性两亲分子,阳离子两亲分子和靶向两亲分子。 任选地,阳离子和靶向两亲分子也是交联的。 存在于靶向两亲性分子上的靶向部分提供复合物到预定靶位点的选择性递送,例如。 血管,内皮细胞,肿瘤细胞,肝细胞等。

    USE OF TARGETED CROSS-LINKED NANOPARTICLES FOR IN VIVO GENE DELIVERY
    7.
    发明申请
    USE OF TARGETED CROSS-LINKED NANOPARTICLES FOR IN VIVO GENE DELIVERY 失效
    使用针对性的交联纳米颗粒在体内基因交付中的应用

    公开(公告)号:US20090048201A1

    公开(公告)日:2009-02-19

    申请号:US12195261

    申请日:2008-08-20

    摘要: The in vivo delivery of nucleic acids is targeted by delivery of the nucleic acid in a complex with cross-linked nanoparticles; where the nanoparticles comprise cross-linked neutral amphipathic molecules, cationic amphipathic molecules and targeting amphipathic molecules. Optionally the cationic and targeting amphipathic molecules are also cross-linked. A targeting moiety present on the targeting amphipathic molecule provides for selective delivery of the complex to a predetermined target site, e.g. blood vessels, endothelial cells, tumor cells, liver cells, and the like.

    摘要翻译: 核酸的体内递送通过将核酸递送到具有交联纳米颗粒的复合物中来靶向; 其中纳米颗粒包含交联的中性两亲分子,阳离子两亲分子和靶向两亲分子。 任选地,阳离子和靶向两亲分子也是交联的。 存在于靶向两亲性分子上的靶向部分提供复合物到预定靶位点的选择性递送,例如。 血管,内皮细胞,肿瘤细胞,肝细胞等。

    Targeted cross-linked nanoparticles and their use in vivo gene delivery
    8.
    发明授权
    Targeted cross-linked nanoparticles and their use in vivo gene delivery 失效
    靶向交联纳米颗粒及其在体内基因递送中的应用

    公开(公告)号:US08163305B2

    公开(公告)日:2012-04-24

    申请号:US12195261

    申请日:2008-08-20

    摘要: The in vivo delivery of nucleic acids is targeted by delivery of the nucleic acid in a complex with cross-linked nanoparticles; where the nanoparticles comprise cross-linked neutral amphipathic molecules, cationic amphipathic molecules and targeting amphipathic molecules. Optionally the cationic and targeting amphipathic molecules are also cross-linked. A targeting moiety present on the targeting amphipathic molecule provides for selective delivery of the complex to a predetermined target site, e.g. blood vessels, endothelial cells, tumor cells, liver cells, and the like.

    摘要翻译: 核酸的体内递送通过将核酸递送到具有交联纳米颗粒的复合物中来靶向; 其中纳米颗粒包含交联的中性两亲分子,阳离子两亲分子和靶向两亲分子。 任选地,阳离子和靶向两亲分子也是交联的。 存在于靶向两亲性分子上的靶向部分提供复合物到预定靶位点的选择性递送,例如。 血管,内皮细胞,肿瘤细胞,肝细胞等。